Updated survival outcomes of NEJ005/TCOG0902: A randomised phase II study of concurrent versus sequential alternating gefitinib and chemotherapy in previously untreated non-small cell lung cancer with sensitive EGFR mutations

North East Japan Study Group and Tokyo Cooperative Oncology Group

Research output: Contribution to journalArticle

14 Citations (Scopus)

Fingerprint Dive into the research topics of 'Updated survival outcomes of NEJ005/TCOG0902: A randomised phase II study of concurrent versus sequential alternating gefitinib and chemotherapy in previously untreated non-small cell lung cancer with sensitive EGFR mutations'. Together they form a unique fingerprint.

Medicine & Life Sciences